Website Preloader
Our Insights

Our insights

As access experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the latest expanded access activity and insights.

"
"
Cross-border Expanded Access Programs: Reducing barriers to treatment access

Cross-border Expanded Access Programs: Reducing barriers to treatment access

Three key steps to bring EAPs to a global market

Three key steps to bring EAPs to a global market

Evaluating the cost impact of an Expanded Access Program

Evaluating the cost impact of an Expanded Access Program

Implementing real-world data collection in Expanded Access Programs (EAPs)

Implementing real-world data collection in Expanded Access Programs (EAPs)

The real value of mapping the Expanded Access Program (EAP) ecosystem

The real value of mapping the Expanded Access Program (EAP) ecosystem

Optimizing commercial launch for orphan drugs with Expanded Access Programs

Optimizing commercial launch for orphan drugs with Expanded Access Programs

New partnership announcement

New partnership announcement

Global Early Access Program for new medicine

Global Early Access Program for new medicine

The Expanded Access Program (EAP) playbook

The Expanded Access Program (EAP) playbook

Uniphar to run pan-European Managed Access Program for new epilepsy drug

Uniphar to run pan-European Managed Access Program for new epilepsy drug

COVID-19 is no obstacle to Expanded Access

COVID-19 is no obstacle to Expanded Access

Marinus Pharmaceuticals initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV

Marinus Pharmaceuticals initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV